MONITORING OF RECOMBINANT HIRUDIN: ASSESSMENT OF A PLASMA-BASED ECARIN CLOTTING TIME ASSAY

This publication has 12 references indexed in Scilit:

• A Comparison of Recombinant Hirudin with Heparin for the Treatment of Acute Coronary Syndromes
  New England Journal of Medicine, 1996
• Quantitative Determination of Hirudin in Blood and Body Fluids
  Seminars in Thrombosis and Hemostasis, 1996
• Hirudin and Excess Bleeding Implications For Future Use
  Drug Safety, 1995
• Evaluation of an automated chromogenic substrate assay for the rapid determination of hirudin in plasma
  Thrombosis Research, 1995
• Safety observations from the pilot phase of the randomized r-Hirudin for Improvement of Thrombolysis (HIT-III) study. A study of the Arbeitsgemeinschaft Leitender Kardiologischer Krankenhausärzte (ALKK)
  Circulation, 1994
• Randomized trial of intravenous heparin versus recombinant hirudin for acute coronary syndromes. The Global Use of Strategies to Open Occluded Coronary Arteries (GUSTO) IIa Investigators.
  Circulation, 1994
• Hirudin in acute myocardial infarction. Safety report from the Thrombolysis and Thrombin Inhibition in Myocardial Infarction (TIMI) 9A Trial.
  Circulation, 1994
• Recombinant hirudin in patients with chronic, stable coronary artery disease. Safety, half-life, and effect on coagulation parameters.
  Circulation, 1993
• Biologic effects of recombinant hirudin (CGP 39393) in human volunteers
  Journal of the American College of Cardiology, 1993
• Mechanisms of α-thrombin and β-thrombin-E formation: Use of ecarin for isolation of meizothrombin 1
  Thrombosis Research, 1980